No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs140599089 |
chr15:79030197-79030198 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs370956291 |
chr15:79030203-79030204 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs556588762 |
chr15:79030263-79030264 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs192172050 |
chr15:79030389-79030390 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs58717592 |
chr15:79030417-79030418 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs143778930 |
chr15:79030423-79030424 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs527724873 |
chr15:79030431-79030432 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs564263209 |
chr15:79030440-79030441 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs148137563 |
chr15:79030442-79030443 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs75150160 |
chr15:79030479-79030480 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs150271650 |
chr15:79030485-79030486 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs11852970 |
chr15:79030486-79030487 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs11852909 |
chr15:79030499-79030500 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs367940745 |
chr15:79030507-79030508 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs11856441 |
chr15:79030526-79030527 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs142705205 |
chr15:79030543-79030544 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs554248921 |
chr15:79030549-79030550 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs374144867 |
chr15:79030565-79030566 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs11852887 |
chr15:79030578-79030579 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs35602248 |
chr15:79030598-79030599 |
Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
21 |
rs556412688 |
chr15:79030617-79030618 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs537704652 |
chr15:79030621-79030622 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs184525955 |
chr15:79030649-79030650 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs370384470 |
chr15:79030651-79030652 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs76412132 |
chr15:79030671-79030672 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs76681511 |
chr15:79030672-79030673 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs75884254 |
chr15:79030673-79030674 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs11853608 |
chr15:79030693-79030694 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs573413325 |
chr15:79030752-79030753 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs561138798 |
chr15:79030783-79030784 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs535844172 |
chr15:79030797-79030798 |
Enhancers Active TSS Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs12906165 |
chr15:79030830-79030831 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs374779038 |
chr15:79030835-79030836 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs565134599 |
chr15:79030837-79030838 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs12906022 |
chr15:79030838-79030839 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs77786718 |
chr15:79030876-79030877 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs77097561 |
chr15:79030877-79030878 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs71402965 |
chr15:79030881-79030882 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs577748792 |
chr15:79030936-79030937 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs377293461 |
chr15:79030968-79030969 |
Enhancers Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs71402966 |
chr15:79031059-79031060 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs71402967 |
chr15:79031079-79031080 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs190008454 |
chr15:79031138-79031139 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
44 |
rs112723723 |
chr15:79031139-79031140 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs370700365 |
chr15:79031160-79031161 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs189653214 |
chr15:79031170-79031171 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs74200924 |
chr15:79031172-79031173 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs61468666 |
chr15:79031174-79031175 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs12906664 |
chr15:79031182-79031183 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs201838421 |
chr15:79031191-79031192 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|